袢利尿剂与肾移植受者尿路感染率及髓质巨噬细胞极化标志物表达的关系
在112例成人肾移植受者队列中,袢利尿剂治疗与移植后5年尿路感染率显著相关。袢利尿剂剂量增加与移植肾髓质M1/M2巨噬细胞标志物比值降低相关,且患者皮质-髓质CCL2梯度减弱、血清CCL2水平显著下降。体外实验显示氯化钠浓度剂量依赖性增加CCL2产生。
要点
- 袢利尿剂治疗与肾移植后5年尿路感染率显著相关
- 袢利尿剂剂量增加与移植肾髓质M1/M2巨噬细胞标志物比值降低相关
- 袢利尿剂治疗患者皮质-髓质CCL2梯度减弱且血清CCL2显著下降
核心结论
- 袢利尿剂治疗与肾移植后菌尿和白细胞尿增加及肾髓质M1/M2巨噬细胞标志物比值降低相关。
- 调整利尿剂治疗应作为频繁尿路感染患者的潜在干预策略进一步研究。
研究设计与样本
- 队列研究纳入112例成人肾移植受者,分析袢利尿剂治疗与移植后5年尿路感染率的相关性。
- 采用单因素和多因素回归分析,并检测移植肾活检中巨噬细胞标志物及体外细胞实验。
主要发现
- 单因素和多因素回归分析显示袢利尿剂治疗与移植后5年尿路感染率显著相关。
- M1标志物HLA-DR和M2标志物CD206与泛巨噬细胞标志物CD68共定位,两者在肾髓质均比皮质更常见。
- 袢利尿剂剂量增加与早期监测活检中肾髓质M1/M2巨噬细胞标志物比值降低相关。
- 体外实验显示氯化钠浓度剂量依赖性增加人髓系和肾小管上皮细胞的CCL2产生。
- 袢利尿剂治疗患者肾皮质-髓质CCL2梯度减弱且血清CCL2水平显著下降。
关键数值与推荐
- 袢利尿剂治疗与移植后5年尿路感染率显著相关(单因素和多因素回归分析)。
- 袢利尿剂剂量增加与肾髓质M1/M2巨噬细胞标志物比值降低相关(早期监测活检)。
- 袢利尿剂治疗患者皮质-髓质CCL2梯度减弱且血清CCL2水平显著下降。
临床怎么用
- 对肾移植后频繁发生尿路感染的患者,应评估袢利尿剂使用并考虑调整利尿剂治疗。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Loop diuretics deplete the renal cortico-medullary salt gradient that has recently been established as a major modulator of immune responses. Renal transplant recipients suffer from a markedly increased rate of urinary tract infections (UTIs). Whether diuretic therapy affects renal macrophage polarization in the human kidney graft and the incidence of UTI have not been reported. In a cohort of 112 adult renal allograft recipients, loop diuretic therapy significantly correlated with the rate of UTI during five years after transplantation in uni- and multivariable regression analysis. The M1 macrophage marker human leukocyte antigen-DR (HLA-DR) and the M2 macrophage marker CD206 co-localized with the pan-macrophage marker CD68 in the kidney graft. Both were more common in renal medulla than cortex. With increasing loop diuretic dose, the renal medullary M1/M2 macrophage marker ratio decreased in early surveillance biopsies of this cohort. In vitro, the sodium chloride concentration dose-dependently increased monocyte chemotactic cytokine CCL2 production in human myeloid and renal tubular epithelial cells. More CCL2 was detected in the renal medulla than cortex of the kidney grafts. However, in patients receiving loop diuretic therapy, the renal cortico-medullary CCL2 gradient was diminished and CCL2 serum levels decreased significantly. Thus, diuretic therapy associated with increased bacteriuria and leukocyturia after kidney transplantation and a decreased M1/M2 macrophage marker ratio in the renal medulla. Hence, adjustment of diuretic therapy should be investigated further as a possible approach in patients with frequent UTIs.
引用
- Casper J, Schmitz J, Bräsen JH, et al. Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression. Kidney Int. 2018. PMID: 30274681. doi:10.1016/j.kint.2018.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。